ICAM-1 +469 A/G polymorphism and cancer risk: a meta-analysis involving 9375 subjects.
CONCLUSION: The evidence from current meta-analysis doesn't support the ICAM-1 +469 A/G polymorphism as a risk factor for cancer. Further studies are needed to validate these findings.
PMID: 24482692 [PubMed]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Wang Y, Jia L, Shen Y, Guo S, Wan C, Yang T, An J, Chen L, Wang T, Wen F Tags: Int J Clin Exp Med Source Type: research